Specifically, the elevation of sAXL was strongest in DAT subjects compared to SCD and HC, and otherwise only elevated in subjects with full AD profile (A+T+ or A+N+, respectively). This evidence concerns the gene SLC6A3 and Schnyder corneal dystrophy.